Previous issues
Editorials
3D quantitative coronary angiography based vessel FFR: clinical evidence and future perspectives
REC Interv Cardiol. 2023;5:91-93
Class effect in TAVI: the time has come to know if they are all the same
REC Interv Cardiol. 2023;5:89-90
Original Articles
Transcatheter aortic valve implantation using Evolut PRO versus SAPIEN 3 valves: a randomized comparative trial
REC Interv Cardiol. 2023;5:94-101
Clinical outcomes of patients undergoing percutaneous coronary intervention treated with colchicine
REC Interv Cardiol. 2023;5:110-117
Regional differences in STEMI care in Spain. Data from the ACI-SEC Infarction Code Registry
REC Interv Cardiol. 2023;5:118-128
Prospective assessment of clinical outcomes of transcatheter aortic valve implantation in a cohort of patients based on their risk profile
REC Interv Cardiol. 2023;5:102-109
Neonatal transcatheter pulmonary valve perforation. Evolution from transfemoral to transjugular approach
REC Interv Cardiol. 2023;5:129-135
Debate
Debate: Revascularization of non-culprit lesions in ACS: physiology, OCT-guided or both? Perspective from physiology
REC Interv Cardiol. 2023;5:136-138
Debate. Revascularization of nonculprit lesions in ACS: physiology or OCT-guided or both? Perspective from imaging
REC Interv Cardiol. 2023;5:139-141
Clinical Case
Intracoronary fibrinolysis as a bailout strategy for massive thrombotic catastrophe
REC Interv Cardiol. 2023;5:151-157
Intracoronary fibrinolysis as a bailout strategy for massive thrombotic catastrophe. How would I approach it?
REC Interv Cardiol. 2023;5:151-157
Intracoronary fibrinolysis as a bailout strategy for massive thrombotic catastrophe. Case resolution
REC Interv Cardiol. 2023;5:151-157
Images in cardiology
Atrial mass as a complication following complex percutaneous coronary intervention
REC Interv Cardiol. 2023;5:160-161
The forgotten stent
REC Interv Cardiol. 2023;5:158-159
Transcatheter aortic valve implantation using FEops HEARTguide co-registration
REC Interv Cardiol. 2023;5:162-163
Scientific letters
Coronary thrombus after cannabis consumption: the important role of intracoronary imaging modalities
REC Interv Cardiol. 2023;5:142-150
Early experience with the FlowTriever thrombectomy system to treat pulmonary embolism
REC Interv Cardiol. 2023;5:142-150
First experience in Spain with PiCSO therapy in patients with acute myocardial infarction
REC Interv Cardiol. 2023;5:142-150
Role of drug-coated balloon in the management of very late stent thrombosis
REC Interv Cardiol. 2023;5:142-150
Editorials
Transcatheter aortic valve replacement for noncalcified aortic regurgitation. Where are we now?
aServicio de Cardiología, Hospital Clínico Universitario, Valladolid, Spain
bCentro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
Original articles
Editorials
Vascular closure devices: the jury is still out
aUnidad de Hemodinámica, Servicio de Cardiología, Hospital General Universitario Dr. Balmis, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain
bDepartamento de Medicina Clínica, Universidad Miguel Hernández, Alicante, Spain
Original articles
Debate
Debate: Asymptomatic severe aortic stenosis: when should we intervene?
The clinician’s perspective
Servicio de Cardiología, Hospital Ramón y Cajal, Madrid, Spain
The interventional cardiologist’s perspective
Unidad de Cardiología Intervencionista, Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, Spain